Document is current
Any future updates will be listed below
-
Authors
Lemke, Oliver https://orcid.org/0000-0002-5104-1836
Heineike, Benjamin Murray
Viknander, Sandra
Cohen, Nir https://orcid.org/0000-0002-5634-1643
Li, Feiran https://orcid.org/0000-0001-9155-5260
Steenwyk, Jacob Lucas https://orcid.org/0000-0002-8436-595X
Spranger, Leonard https://orcid.org/0000-0002-4316-2961
Agostini, Federica https://orcid.org/0000-0002-4255-4867
Lee, Cory Thomas
Aulakh, Simran Kaur
Berman, Judith https://orcid.org/0000-0002-8577-0084
Rokas, Antonis https://orcid.org/0000-0002-7248-6551
Nielsen, Jens
Gossmann, Toni Ingolf https://orcid.org/0000-0001-6609-4116
Zelezniak, Aleksej https://orcid.org/0000-0002-3098-9441
Ralser, Markus https://orcid.org/0000-0001-9535-7413
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 28 May 2025
First Online: 9 July 2025
Competing interests
: M.R. and A.Z. are founders and shareholders of Eliptica. J.L.S. is an adviser for ForensisGroup. J.L.S. is a scientific consultant for FutureHouse. Over the course of this project, J.L.S. was a Bioinformatics Visiting Scholar at MantleBio. A.R. is a scientific consultant for LifeMine Therapeutics. The other authors declare no competing interests.
